SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
ICCM

IceCure Medical Ltd. (NASDAQ:ICCM)

IL · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$0.80-$0.20 (-19.71%)
 
Market cap
$1.80M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 26, 2021
Market Cap$1.80M-96.3%
Revenue (ttm)$3.92M+31.8%
Net Income-$17.24M-12.8%
EPS-$5.71+26.9%
Shares Out2.25M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume202,665
Open$0.91
Previous Close$1.00
Day's Range$0.77 - $0.91
52-Week Range$0.65 - $22.20
Beta0.43
AnalystsBuy
Price Target$1.00(+24.91%)
Earnings DateMar 16, 2027
-15.76% (1D)
No price history available.

About ICCM

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

Address
7 Ha’Eshel Street, Caesarea, HA, 3079504, IL
Market Cap
2 million
Employees
68
Industrial Classification
Medical - Devices
Financial Health Score
Weak
From ICCM’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-19.71%
5 Days
+2.64%
1 Month
-19.94%
6 Months
-88.64%
1 Year
-96.26%

$ICCM stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ICCM holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ICCM's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ICCM Estimated quarterly lobbying spending

Source: U.S. Senate LDA

ICCM Revenue by Segment or Geography

ICCM's latest filing doesn't break out revenue by segment.

Source: SEC EDGAR (10-Q/10-K)

U.S. Patents

New ICCM patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ICCM from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from ICCM’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
62% of score
99
News & Sentiment
38% of score
72

News check: Strong YoY sales growth and geographic expansion offset Q3 loss and revenue miss; new patent grants add IP strength.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.